BR0214552A - Compound or a pharmaceutically acceptable acid addition salt thereof, pharmaceutical composition, use of the compound or pharmaceutically acceptable acid addition salt thereof, and method for treating a disease - Google Patents

Compound or a pharmaceutically acceptable acid addition salt thereof, pharmaceutical composition, use of the compound or pharmaceutically acceptable acid addition salt thereof, and method for treating a disease

Info

Publication number
BR0214552A
BR0214552A BR0214552-9A BR0214552A BR0214552A BR 0214552 A BR0214552 A BR 0214552A BR 0214552 A BR0214552 A BR 0214552A BR 0214552 A BR0214552 A BR 0214552A
Authority
BR
Brazil
Prior art keywords
pharmaceutically acceptable
acid addition
addition salt
acceptable acid
compound
Prior art date
Application number
BR0214552-9A
Other languages
Portuguese (pt)
Inventor
Garrick Paul Smith
Gitte Mikkelsen
Kim Andersen
Daniel Greve
Thomas Ruhland
Stephen P Wren
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2002/000859 external-priority patent/WO2003053942A1/en
Publication of BR0214552A publication Critical patent/BR0214552A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSTO OU UM SEU SAL DE ADIçãO DE áCIDO FARMACEUTICAMENTE ACEITáVEL, COMPOSIçãO FARMACêUTICA, USO DO COMPOSTO OU DO SEU SAL DE ADIçãO DE áCIDO FARMACEUTICAMENTE ACEITáVEL, E, MéTODO PARA O TRATAMENTO DE UMA DOENçA". A invenção proporciona compostos de fórmula (1) na qual os substituintes são como definidos no pedido. Os compostos são inibidores do transporte de glicina valiosos."COMPOUND OR ITS PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT, PHARMACEUTICAL COMPOSITION, USE OF THE PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT AND METHOD FOR TREATMENT OF A DISEASE". The invention provides compounds of formula (1) wherein the substituents are as defined in the application. The compounds are valuable glycine transport inhibitors.

BR0214552-9A 2001-12-20 2002-12-16 Compound or a pharmaceutically acceptable acid addition salt thereof, pharmaceutical composition, use of the compound or pharmaceutically acceptable acid addition salt thereof, and method for treating a disease BR0214552A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101927 2001-12-20
PCT/DK2002/000859 WO2003053942A1 (en) 2001-12-20 2002-12-16 Aryloxyphenyl and arylsulfanylphenyl derivatives

Publications (1)

Publication Number Publication Date
BR0214552A true BR0214552A (en) 2004-11-09

Family

ID=33442600

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214552-9A BR0214552A (en) 2001-12-20 2002-12-16 Compound or a pharmaceutically acceptable acid addition salt thereof, pharmaceutical composition, use of the compound or pharmaceutically acceptable acid addition salt thereof, and method for treating a disease

Country Status (8)

Country Link
KR (1) KR20040073439A (en)
AR (1) AR037933A1 (en)
BR (1) BR0214552A (en)
EA (1) EA007475B1 (en)
PL (1) PL368985A1 (en)
TW (1) TW200410938A (en)
UA (1) UA76259C2 (en)
ZA (1) ZA200403665B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2267114A1 (en) * 1996-10-21 1998-04-30 Neurosearch A/S 1-phenyl-benzimidazole compounds and their use as gaba-a receptor modulators

Also Published As

Publication number Publication date
EA200400837A1 (en) 2004-12-30
EA007475B1 (en) 2006-10-27
ZA200403665B (en) 2005-05-13
UA76259C2 (en) 2006-07-17
AR037933A1 (en) 2004-12-22
PL368985A1 (en) 2005-04-04
TW200410938A (en) 2004-07-01
KR20040073439A (en) 2004-08-19

Similar Documents

Publication Publication Date Title
BR0212042A (en) Compound, pharmaceutical composition, method of treating or preventing disease, and use of a compound
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
BR0312464A (en) Tyrosine kinase inhibitors
BR0215312A (en) Use of a compound, method for inhibiting aurora kinase in a warm-blooded animal, compound, pharmaceutical composition, and process for preparing a compound
BR9911482A (en) Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BR0215240A (en) Calcium derivatives and their use in treating diseases
EA200400432A1 (en) UREA DERIVATIVES
EA200300776A1 (en) FENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
BR0211119A (en) Compound, method of treating a patient who has, or preventing a patient from catching, a disease or condition, use of a compound, and method for making a compound
BR0109703A (en) Piperazine Derivatives
BR0213242A (en) Compound or a salt or solvate thereof, compound and physiologically acceptable acid addition salts thereof, pharmaceutical composition, method of treating one or more disorders, use of a compound, and process of preparing a compound
BR0212346A (en) A compound or a pharmaceutically acceptable salt, solvate, solvate of this salt or a prodrug thereof, process for the preparation thereof, use thereof, method for producing an ibat inhibitory effect on a warm-blooded animal such as a human in need for this treatment and pharmaceutical composition
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
ECSP055701A (en) NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME
BR0212078A (en) Method of treating or preventing an amyloid-related disease in a patient, pharmaceutical composition, chemical compound, and use of a compound.
BR0316458A (en) Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound
EA200601846A1 (en) CONTAINING BENZOXASINS MEDICINAL COMBINATIONS FOR THE TREATMENT OF DISEASES OF RESPIRATORY TRACKS
BR0309342A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
BR0213139A (en) Compound, method of treating or preventing disease and preparing a compound, use of a compound and pharmaceutical composition
BR0309343A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
BR0212787A (en) Pharmaceutically acceptable compound or salt thereof, methods of treating or preventing disease and preparing a compound, use of a compound or salt, and pharmaceutical composition
BR0211118A (en) Compound, methods for treating or preventing disease and for making a compound, intermediate, and use of a compound or salt
BR0315580A (en) Methylene Urea Derivatives
BR9812492A (en) Compound, use of it, pharmaceutical formulation, and processes for the treatment of cardiovascular disease, for the treatment of vasoconstriction, and for the preparation of compounds
EA200400086A1 (en) NEW OXAZOLIDINON DERIVATIVES AS ANTIBACTERIAL AGENTS

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2034 DE 29/12/2009.